661 related articles for article (PubMed ID: 29547971)
21. Recent developments in bacterial conjugate vaccines.
Goldblatt D
J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559
[TBL] [Abstract][Full Text] [Related]
22. An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.
Khatun F; Stephenson RJ; Toth I
Chemistry; 2017 Mar; 23(18):4233-4254. PubMed ID: 28097690
[TBL] [Abstract][Full Text] [Related]
23. Vaccines based on the cell surface carbohydrates of pathogenic bacteria.
Jones C
An Acad Bras Cienc; 2005 Jun; 77(2):293-324. PubMed ID: 15895165
[TBL] [Abstract][Full Text] [Related]
24. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
[TBL] [Abstract][Full Text] [Related]
25. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
26. A semisynthetic
Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
[TBL] [Abstract][Full Text] [Related]
27. Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach.
Seeberger PH
Chem Rev; 2021 Apr; 121(7):3598-3626. PubMed ID: 33794090
[TBL] [Abstract][Full Text] [Related]
28. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
[TBL] [Abstract][Full Text] [Related]
29. Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies.
Chen L; Valentine JL; Huang CJ; Endicott CE; Moeller TD; Rasmussen JA; Fletcher JR; Boll JM; Rosenthal JA; Dobruchowska J; Wang Z; Heiss C; Azadi P; Putnam D; Trent MS; Jones BD; DeLisa MP
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3609-18. PubMed ID: 27274048
[TBL] [Abstract][Full Text] [Related]
30. Pseudaminic Acid on Exopolysaccharide of Acinetobacter baumannii Plays a Critical Role in Phage-Assisted Preparation of Glycoconjugate Vaccine with High Antigenicity.
Lee IM; Yang FL; Chen TL; Liao KS; Ren CT; Lin NT; Chang YP; Wu CY; Wu SH
J Am Chem Soc; 2018 Jul; 140(28):8639-8643. PubMed ID: 29965749
[TBL] [Abstract][Full Text] [Related]
31. Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine.
Torres AG; Gregory AE; Hatcher CL; Vinet-Oliphant H; Morici LA; Titball RW; Roy CJ
Vaccine; 2015 Jan; 33(5):686-92. PubMed ID: 25533326
[TBL] [Abstract][Full Text] [Related]
32. Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V Polysaccharide.
Nilo A; Passalacqua I; Fabbrini M; Allan M; Usera A; Carboni F; Brogioni B; Pezzicoli A; Cobb J; Romano MR; Margarit I; Hu QY; Berti F; Adamo R
Bioconjug Chem; 2015 Aug; 26(8):1839-49. PubMed ID: 26230938
[TBL] [Abstract][Full Text] [Related]
33. Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need.
Cox AD; Williams D; Cairns C; St Michael F; Fleming P; Vinogradov E; Arbour M; Masson L; Zou W
Vaccine; 2017 Oct; 35(45):6129-6136. PubMed ID: 28951087
[TBL] [Abstract][Full Text] [Related]
34. Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.
Colombo C; Pitirollo O; Lay L
Molecules; 2018 Jul; 23(7):. PubMed ID: 30011851
[TBL] [Abstract][Full Text] [Related]
35. The role of vaccines in fighting antimicrobial resistance (AMR).
Jansen KU; Anderson AS
Hum Vaccin Immunother; 2018; 14(9):2142-2149. PubMed ID: 29787323
[TBL] [Abstract][Full Text] [Related]
36. Protection against Experimental Melioidosis with a Synthetic manno-Heptopyranose Hexasaccharide Glycoconjugate.
Scott AE; Christ WJ; George AJ; Stokes MG; Lohman GJ; Guo Y; Jones M; Titball RW; Atkins TP; Campbell AS; Prior JL
Bioconjug Chem; 2016 Jun; 27(6):1435-46. PubMed ID: 27124182
[TBL] [Abstract][Full Text] [Related]
37. Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines.
Moeller TD; Weyant KB; DeLisa MP
Adv Biochem Eng Biotechnol; 2021; 175():355-378. PubMed ID: 30143807
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence High-Throughput Screening for Inhibitors of TonB Action.
Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE
J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720
[TBL] [Abstract][Full Text] [Related]
39. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
Titball RW; Burtnick MN; Bancroft GJ; Brett P
Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210
[TBL] [Abstract][Full Text] [Related]
40. Conjugate vaccines--a breakthrough in vaccine development.
Mäkelä PH
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
